# FDA Inspection 806766 - KLEB, Inc - November 09, 2012

Source: https://www.keypedia.com/records/fda_inspections/kleb-inc/af476afd-d06e-4bff-b92f-3b8870dcc0bf
Source feed: FDA_Inspections

> FDA Inspection 806766 for KLEB, Inc on November 09, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 806766
- Company Name: KLEB, Inc
- Inspection Date: 2012-11-09
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1163378 - 2022-02-23](https://www.keypedia.com/records/fda_inspections/kleb-inc/d5bc3441-c778-4ed5-817e-4191df67e90c)
- [FDA Inspection 1163378 - 2022-02-23](https://www.keypedia.com/records/fda_inspections/kleb-inc/d99d61c6-9f6d-4a02-937e-3ef536f891b2)
- [FDA Inspection 1163378 - 2022-02-23](https://www.keypedia.com/records/fda_inspections/kleb-inc/7e957d3f-5612-4e98-a7c9-5343b8c72243)
- [FDA Inspection 1076519 - 2018-12-19](https://www.keypedia.com/records/fda_inspections/kleb-inc/7aa9bfe1-e0b0-4ed8-a3a6-94d9850e9dba)
- [FDA Inspection 993737 - 2016-12-08](https://www.keypedia.com/records/fda_inspections/kleb-inc/1170e277-3c74-412d-ae66-f943a1fd9ca9)

Company: https://www.keypedia.com/companies/kleb-inc/430029a6-70a0-4628-a57a-e67b8e437351

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d